For decades, older Americans enrolled in Medicare faced a simple reality when it came to obesity medications: federal law said no. Weight loss drugs were...
Weight-Loss
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] India faces a growing challenge with overweight and obesity. This nation of over 1.4 billion people has the third...
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking...
[stock_market_widget type=”card” template=”basic2″ assets=”LLY” realtime=”true” api=”yahoo-finance”] Eli Lilly (NYSE: LLY) just announced plans to invest $3.5 billion in a new manufacturing plant in Pennsylvania’s Lehigh...
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO, CSE: NOVO-B) starts selling the first oral GLP-1 drug for weight loss in the...
[stock_market_widget type=”card” template=”basic2″ assets=”PFE” realtime=”true” api=”yahoo-finance”] In a move that has escalated competition in the growing obesity treatment market, Danish pharmaceutical company Novo Nordisk A/S...
